	US 12,403,122 B2
	Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
Thomas Christian Lines, Oberwil-Lieli (CH)
Assigned to QUERCIS PHARMA AG, Zug (CH)
Filed by Quercis Pharma AG, Zug (CH)
Filed on May 19, 2022, as Appl. No. 17/664,184.
Claims priority of provisional application 63/190,697, filed on May 19, 2021.
Prior Publication US 2022/0370401 A1, Nov. 24, 2022
Int. Cl. A61K 31/352 (2006.01); A61K 31/375 (2006.01); A61K 31/404 (2006.01); A61K 31/455 (2006.01); A61K 31/519 (2006.01); A61P 21/00 (2006.01); A61P 25/28 (2006.01)

CPC A61K 31/352 (2013.01) [A61K 31/375 (2013.01); A61K 31/404 (2013.01); A61K 31/455 (2013.01); A61K 31/519 (2013.01); A61P 21/00 (2018.01); A61P 25/28 (2018.01)]

13 Claims

1. A method of treating amyotrophic lateral sclerosis (ALS), the method comprising administering to a subject in need thereof an effective amount of a first pharmaceutical composition comprising isoquercetin, vitamin B3, vitamin C, and a second pharmaceutical composition comprising zafirlukast.